AHE ASX · Health Care

Adheris Health Ltd

Announcements, last 12 months: 66
Price sensitive, last 12 months: 12
Followed on InvestorPA: Moderate (Among the 13% most-followed companies on InvestorPA)

Latest announcements

Released	Headline	Actions
19 Oct 2026, 5:07 PM	Notice of Annual General Meeting/Proxy Form
7 Oct 2026, 9:51 AM	Change of Year End Date and Functional Currency
2 Oct 2026, 2:45 PM	Ceasing to be a substantial holder from EBO
1 Oct 2026, 5:46 PM	Change in substantial holding
1 Oct 2026, 11:39 AM	Change of Director's Interest Notice x4
1 Oct 2026, 11:31 AM	Adheris Board and Management Increase Shareholdings
1 Sep 2026, 10:33 AM	FY26 Results Presentation
31 Aug 2026, 5:36 PM	Change of Chief Financial Officer
31 Aug 2026, 8:45 AM	Adheris FY26 Results Price sensitive	AI summary
31 Aug 2026, 8:43 AM	FY26 Annual Report

Sign in to see all AHE announcements.

Guidance history

31 Aug 2026	FY26 revenue $34.0M, FY26 gross profit $14.6M, FY26 underlying EBITDA loss $16.5M
31 Aug 2026	Revenues down 46.1% to $33,958,311; loss down 92.8% to $4,309,303
2 Feb 2026	Adheris Health expects to achieve total operating cost savings in excess of 30% over the two-year period from FY25 to FY27, with staff costs expected to drop to approximately $3.6 million in Q4 FY26.

Sign in to see the full guidance history.

Most followed in Health Care

PME Pro Medicus Ltd
AHC Austco Healthcare Ltd
CSL CSL Ltd
RMD Resmed Inc
TLX TELIX Pharmaceuticals Ltd
CGS Cogstate Ltd
ALC Alcidion Group Ltd
CSX Cleanspace Holdings Ltd

Follow AHE to get its announcements emailed to you, with AI summaries, the full announcement and guidance history, and its most significant announcements.